Why is an LBO analysis described as the 'floor' of a valuation football field, and what does the analysis actually solve for?

What the interviewer is actually testing

"Why can a strategic pay more than a sponsor?" and "why would a sponsor ever win?" are among the most common M&A/LBO judgment questions at every level, precisely because they have no formula: they test whether you understand who the buyers are and what math each one runs.

Test 1: Do you know both sides' math? Weak candidates say "synergies" and stop. Strong candidates frame it as two different underwriting models: the strategic values standalone cash flows plus synergies against its WACC with no exit required; the sponsor solves a levered 5-year hold backward from a 20%+ IRR hurdle. Once you frame it that way, every follow-up ("what if rates rise?", "what if the target has no overlap with any strategic?") answers itself.

Test 2: Can you connect it to banker work product? Mentioning that the LBO analysis functions as the floor of the football field (the sponsor's ability-to-pay) and that synergized strategic bids set the top, signals you understand why bankers run the analysis at all, not just how.

Test 3: Entry/exit discipline. Interviewers at PE-heavy shops will press on exit assumptions. The mastery signals: base case exits at the entry multiple so the underwritten return rests on controllable drivers; multiple expansion must be argued from a repositioning thesis, not assumed; buying at cycle peaks argues for underwriting contraction. Volunteering the leverage-market point (that ability-to-pay across the entire sponsor universe moves with credit conditions, which is why purchase multiples and loan markets are correlated) is a genuinely differentiating answer.

Test 4: Judgment under a scenario. Expect a hypothetical: "Same asset, strategic bids 11x, sponsor bids 11.5x: why might that happen?" Good answers: no synergies for that particular strategic, sponsor has a platform to bolt it onto (arbitrage), hot credit markets, management prefers the sponsor, or the strategic's stock would sell off on announcement. Concrete mechanisms beat abstractions here.

Common traps

Trap 1: "Strategics always pay more." It's a tendency, not a law. Sponsors win constantly: when there are no synergies to underwrite, when credit is cheap, when they own a platform (add-on arbitrage makes them quasi-strategic), when speed/certainty matters, or when management backs the sponsor.

Say it out loud: "Strategics can usually justify a higher price because of synergies and a lower cost of capital, but sponsors win on leverage, certainty, buy-and-build arbitrage, and in situations where no natural strategic buyer exists."

Trap 2: Forgetting the sponsor's exit requirement. A sponsor's fund life forces a sale in ~3–7 years, so it must underwrite an exit multiple and a buyer universe. A strategic never has to answer "who do we sell this to?" Omitting this misses one of the cleanest structural differences.

Say it out loud: "The sponsor has to underwrite the exit (multiple, timing, and buyer universe) because the fund must return capital; the strategic holds indefinitely and only needs returns above its cost of capital."

Trap 3: Assuming exit-multiple expansion in the base case. Underwriting a higher exit multiple bakes market luck into the return. Investment committees treat it as a red flag unless there's a specific repositioning thesis.

Say it out loud: "Base case I'd hold the exit multiple flat to entry, so the underwritten return comes from EBITDA growth and debt paydown (the things the sponsor controls). Expansion is upside, not underwriting."

Trap 4: Treating the entry multiple as the sponsor's choice. The auction sets the price. The sponsor's model tests whether the market-clearing price still hits the hurdle. The honest output of an LBO model is the maximum price (ability-to-pay), not a 'fair value.'

Say it out loud: "The LBO doesn't tell you what the business is worth: it tells you the most a sponsor can pay and still hit its return hurdle, which is why it sets the floor of the valuation range."

Trap 5: Comparing headline multiples without synergizing. A strategic paying 10x on $100M EBITDA with $30M of credible synergies is really paying 7.7x. Candidates who compare 10x to a sponsor's 9x and call the strategic 'irrational' miss the effective-multiple math.

Say it out loud: "On synergized EBITDA the strategic's effective multiple is price over EBITDA-plus-synergies, so a 10x headline on $100M with $30M of synergies is 7.7x effective, cheaper than it looks."

Trap 6: Ignoring hold period when quoting hurdle returns. '2x' means nothing without years. 2.0x in 5 years is ~15% IRR; 2.0x in 3 years is ~26%. Ability-to-pay changes materially with the assumed hold.

Say it out loud: "I'd anchor on roughly 2x over five years for about a 15% IRR, or 2.5x for about 20%: the MoIC-to-IRR mapping depends entirely on the hold period."